MedPath

A Randomized Controlled Trial of Exercise Training Among Men With Type 2-diabetes

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Hyperglycemia
Interventions
Behavioral: strength training
Behavioral: Endurance training
Registration Number
NCT00666094
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

To test the hypothesis that there is no difference in change in HbA1C among men with type 2-diabetes after an exercise intervention with strength versus endurance training.

Detailed Description

Exercise training is well documented as part of effective treatment for type 2-diabetes patients. Endurance training has been suggested as the most suitable form of exercise. There are reasons to believe that strength training also has a positive effect. However, comparisons of endurance training and strength training regimes are limited.

Therefore we randomized 26 men with type 2-diabetes to either an endurance training group or a strength training group. Both groups exercised three sessions per week for three months. The training was supervised.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
26
Inclusion Criteria
  • Diagnosed with type 2-diabetes
  • Male, 35-71 years
  • Managing their diabetes through a lifestyle and/or the drug metformin only
  • Able to participate in either of the exercise groups
Exclusion Criteria
  • Symptomatic cardiovascular disease
  • Uncontrolled hypertension
  • Physical or cognitive disabilities that will interfere with participating in the exercise regimes.
  • Trained consistently during the last six months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
strength trainingstrength trainingSupervised strength training
endurance trainingEndurance trainingsupervised endurance training
Primary Outcome Measures
NameTimeMethod
HbA1C12.01.08
Secondary Outcome Measures
NameTimeMethod
body composition, C-peptid, BP, Cholesterol (LDL, HDL), Triglycerides12.01.08

Trial Locations

Locations (1)

NTNU

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath